Why use regular sunscreen when you can apply a DNA film to your skin? Researchers at Binghamton University, State University of New York have developed a coating made out of DNA that gets better at protecting skin from ultraviolet light the more you expose it to the sun, and it also keeps your skin hydrated.
Va. - Deoxyribonucleic acid, more commonly known as DNA, is our body’s biological computer, and it stores information and carries genetic instructions vital to our everyday functions. DNA does this so well, in fact, that scientists are exploring new ways to leverage its capabilities in a way to protect the warfighter.
Researchers in Japan have made a breakthrough in the search for a birth control pill for men after discovering that two commonly used immunosuppressants cause reversible infertility in mice. Cyclosporin A (CsA) and Tacrolimus (FK506) are often given to organ transplant patients to prevent rejection of their new organ. Miyata et al.discovered that the target of these two drugs, an enzyme called calcineurin, is critical for sperm development and motility. They observed that continuously dosing mice with calcineurin inhibitors quickly rendered them sterile, an effect that, importantly, disappeared within a week of stopping treatment.
NeuroPhage Pharmaceuticals, Inc. today announced that the discovery, preclinical development and clinical trial approach for its lead candidate, NPT088, were highlighted in an oral session at the Alzheimer’s Association International Conference (AAIC) taking place July 18–23, 2015, in Washington, D.C. NPT088 contains the general amyloid interaction motif (GAIM), which allows the compound to universally recognize and disrupt the shape of misfolded proteins and target them for degradation through the body’s natural mechanisms. In the data presented at AAIC, administration of NPT088 led to broad beneficial effects in animal models of Alzheimer’s and Parkinson’s diseases, with improvements in memory and cognition and reductions in toxic protein aggregates.
LAB produced red blood cells are set to be transfused into humans by 2017, NHS Blood and Transplant announces. The landmark in-man clinical trials of manufactured blood form a key part of the blood and organ service's 2020 Research and Development programme.